AbbVie seeks FDA approval for non-small cell lung cancer treatment

AbbVie seeks FDA approval for non-small cell lung cancer treatment

Submitted by admin on September 30, 2024 - 9:45am
Source: 
Pharmaceutical Business Review
News Tags: 
AbbVie
FDA
Teliso-V
non-small cell lung cancer
Headline: 
AbbVie seeks FDA approval for non-small cell lung cancer treatment
snippet: 

AbbVie has filed a biologics license application (BLA) with the US Food and Drug Administration (FDA) seeking accelerated approval for telisotuzumab vedotin (Teliso-V) in adult non-small cell lung cancer (NSCLC) patients.

Do Not Allow Advertisers to Use My Personal information